Follow
Grace McComsey, MD
Grace McComsey, MD
Professor of Medicine and Pediatrics, Case Western Reserve University
Verified email at uhhospitals.org
Title
Cited by
Cited by
Year
Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz …
GA McComsey, D Kitch, ES Daar, C Tierney, NC Jahed, P Tebas, L Myers, ...
Journal of Infectious Diseases 203 (12), 1791-1801, 2011
5882011
Weight gain following initiation of antiretroviral therapy: risk factors in randomized comparative clinical trials
PE Sax, KM Erlandson, JE Lake, GA Mccomsey, C Orkin, S Esser, ...
Clinical Infectious Diseases 71 (6), 1379-1389, 2020
5622020
Bone disease in HIV infection: a practical review and recommendations for HIV care providers
GA McComsey, P Tebas, E Shane, MT Yin, ET Overton, JS Huang, ...
Clinical infectious diseases 51 (8), 937-946, 2010
4822010
Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen
TT Brown, GA McComsey, MS King, RB Qaqish, BM Bernstein, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 51 (5), 554-561, 2009
3522009
Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells
MM Lederman, L Calabrese, NT Funderburg, B Clagett, K Medvik, ...
Journal of Infectious Diseases 204 (8), 1217-1226, 2011
3482011
Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor–sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized …
JL Lennox, RJ Landovitz, HJ Ribaudo, I Ofotokun, LH Na, C Godfrey, ...
Annals of internal medicine 161 (7), 461-471, 2014
3062014
Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy
AC Ross, N Rizk, MA O'Riordan, V Dogra, D El-Bejjani, N Storer, D Harrill, ...
Clinical Infectious Diseases 49 (7), 1119-1127, 2009
3022009
Association between systemic inflammation and incident diabetes in HIV-infected patients after initiation of antiretroviral therapy
TT Brown, K Tassiopoulos, RJ Bosch, C Shikuma, GA McComsey
Diabetes care 33 (10), 2244-2249, 2010
2772010
Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D
TT Brown, GA McComsey
Antiviral therapy 15 (3), 425-429, 2010
2262010
Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy
DA Wohl, G McComsey, P Tebas, TT Brown, MJ Glesby, D Reeds, ...
Clinical Infectious Diseases 43 (5), 645-653, 2006
2112006
Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus—infected patients switched from stavudine to abacavir or …
GA McComsey, DJ Ward, SM Hessenthaler, MG Sension, P Shalit, ...
Clinical infectious diseases 38 (2), 263-270, 2004
2112004
Development of a definition of postacute sequelae of SARS-CoV-2 infection
T Thaweethai, SE Jolley, EW Karlson, EB Levitan, B Levy, GA McComsey, ...
Jama 329 (22), 1934-1946, 2023
2102023
Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine
GA McComsey, DM Paulsen, JT Lonergan, SM Hessenthaler, CL Hoppel, ...
Aids 19 (1), 15-23, 2005
2082005
Changing spectrum of mortality due to human immunodeficiency virus: analysis of 260 deaths during 1995–1999
H Valdez, TK Chowdhry, R Asaad, IJ Woolley, T Davis, R Davidson, ...
Clinical infectious diseases 32 (10), 1487-1493, 2001
1952001
Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV
GA McComsey, MA Kendall, P Tebas, S Swindells, E Hogg, ...
Aids 21 (18), 2473-2482, 2007
1792007
Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy
NT Funderburg, Y Jiang, SM Debanne, D Labbato, S Juchnowski, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 68 (4), 396-404, 2015
1682015
Weight gain and integrase inhibitors
AR Eckard, GA McComsey
Current opinion in infectious diseases 33 (1), 10-19, 2020
1612020
Body composition changes after initiation of raltegravir or protease inhibitors: ACTG A5260s
GA McComsey, C Moser, J Currier, HJ Ribaudo, P Paczuski, MP Dubé, ...
Clinical Infectious Diseases 62 (7), 853-862, 2016
1602016
Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy
NT Funderburg, Y Jiang, SM Debanne, N Storer, D Labbato, B Clagett, ...
Clinical Infectious Diseases 58 (4), 588-595, 2014
1512014
Risk factors for weight gain following switch to integrase inhibitor–based antiretroviral therapy
JE Lake, K Wu, SH Bares, P Debroy, C Godfrey, JR Koethe, ...
Clinical Infectious Diseases 71 (9), e471-e477, 2020
1462020
The system can't perform the operation now. Try again later.
Articles 1–20